Mirum Pharmaceuticals, Inc.
MIRM
Revenue
148.93M
▲15.92M▲11.97%
3 Months ChangeAssets
842.81M
▲57.70M▲7.35%
3 Months ChangeLiabilities
528.12M
▲35.05M▲7.11%
3 Months ChangeFree Cash Flow
-2.00M
▼-17.20M▼-113.17%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-25
Form 8-K
ID: 0001759425-26-000010
2026-01-26
Form 8-K
ID: 0001193125-26-022582
2026-01-12
Form 8-K
ID: 0001759425-26-000004
2025-12-19
Form 8-K
ID: 0001193125-25-326822
2025-12-19
Form 8-K
ID: 0001193125-25-325825
2025-12-08
Form 8-K
ID: 0001193125-25-310611
2025-11-17
Form 8-K
ID: 0001759425-25-000057
2025-11-04
Form 10-Q
ID: 0001759425-25-000054
2025-11-04
Form 8-K
ID: 0001759425-25-000053
2025-08-06
Form 10-Q
ID: 0001759425-25-000041